Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted nicotinimide inhibitors of BTK and their preparation and use in the treatment of cancer, inflammation and autoimmune disease

Substituted nicotinimide inhibitors of BTK and their preparation and use in the treatment of cancer, inflammation and autoimmune disease

US Patent 11345695 · Granted May 31, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Perk inhibiting compounds2025
Collections of peptides, peptide agents, and methods of use thereof2025
Indoline-1-formamide compound, preparation method therefor, and medical use ther2025
Indoline-1-formamide compound, preparation method therefor, and medical use ther2025
Perk inhibiting imidazolopyrazine compounds2025
Device and method for evaluating heat capacity of test platform of hydrogen fuel2025
Crystalline forms of (S)-1-(1-acryloylpyrrolidin-3-yl)-3-((3,5-dimethoxyphenyl)e2025
Process for preparing 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinami2025
Amorphous solid dispersion comprising 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyp2024
Substituted nicotinimide inhibitors of BTK for treating cancer2024
Substituted nicotinimide inhibitors of BTK for treating cancer2024
Substituted nicotinimide inhibitors of BTK for treating cancer2024